The American Society of Health-System Pharmacists (ASHP) said Thursday it will hold its first virtual House of Delegates session Nov. 13-20 to give delegates the chance to take early action on ASHP policy recommendations through online discussion and voting. Read More »

During Capitol Hill Health Fair on Wednesday, APhA will urge lawmakers to back pharmacy bill Read More »

The U.S. Food and Drug Administration (FDA) recently approved Dyanavel XR (amphetamine), extended-release oral suspension, CII, for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children six years and older, according to an announcement from Tris Pharma Inc. on Tuesday. Read More »

The ‘authorized generic’ version of a drug is an important product consideration for patients, an executive at Sanofi US advised. Read More »

The U.S. Food and Drug Administration (FDA) on Tuesday approved Coagadex for hereditary Factor X (10) deficiency. Read More »

American Society of Health-System Pharmacists (ASHP) on Wednesday announced that there are now 2,000 residency programs across the country currently undergoing the ASHP accreditation process. Read More »

NCPA recommended improvements to benefit patients and taxpayers at a recent House Energy and Commerce Subcommittee on Health hearing about medication therapy management (MTM) in the Medicare Part D program. Read More »

LEO Pharma recently announced that Enstilar Foam for plaque psoriasis has been approved by the U.S. Food and Drug Administration. Read More »

Aetna and Rush Health on Oct. 15 announced a collaboration to launch Aetna Whole Health Chicago, a commercial healthcare product in Illinois that will give members access to coordinated care. Read More »

National Community Pharmacists Association (NCPA) data released Oct.13 indicates that despite decreasing prescription reimbursements and the narrowing of pharmacy networks, the nation's independent community pharmacies continue to beat the odds and diversify their revenues. Read More »

Aetna said its shareholders voted Monday to approve the issuance of Aetna common shares to Humana stockholders in connection with Aetna’s proposed acquisition of Humana. Read More »

Health Mart pharmacies said Monday it is gearing up for its third series of town hall events. This series, titled “Get in Sync: Medication Synchronization,” is aimed at getting pharmacists to think about adopting appointment-based models with medication synchronization to take them from reactive prescription filling to proactive and patient-centric filling. Read More »

The American Society of Health-System Pharmacists (ASHP) said Friday it is disappointed with the recent decision of the U.S District Court for the District of Columbia that will omit all drugs with an “orphan” designation from the 340B Drug Pricing Program for rural and cancer hospitals. Read More »

The 28th annual McKesson Health Solutions Conference  (MHSC) kicked off Monday at the Aria Resort and Casino in Las Vegas. More than 300 health care professionals from leading payers and providers will engage in networking, learning and focusing on a better future for health care at the conference that runs through Thursday. Read More »

AstraZeneca said the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) about the new drug application (NDA) for the investigational fixed-dose combination of saxagliptin and dapagliflozin. The fixed-dose combination of saxagliptin and dapagliflozi is intended for the treatment of adult patients with Type 2 diabetes.  The CRL said more clinical data is required to support NDA. Read More »

The National Community Pharmacists Association (NCPA) said Oct. 14 its House of Delegates named a new president and approved policy resolutions to advance patient care and tackle problems affecting businesses at the 2015 NCPA Annual Convention. Read More »

Xerox issued an update Oct. 13 on the strategic direction of its government health care business, focusing the implementation of its Health Enterprise Medicaid platform in California and Montana.Based on discussions with clients in California and Montana, Xerox said is likely it will not fully complete the implementation of the Health Enterprise Medicaid platform, its next-generation Medicaid Management Information System, in these states. Xerox said it expects to continue to process Medicaid cl Read More »

340B Health said Oct. 14 it is disappointed with a recent federal district court ruling that will drastically raise the cost of orphan drugs for rural and cancer hospitals and their patients. "This is a major setback for rural hospitals who are already struggling to keep their doors open,"  340B Health President and CEO Ted Slafsky said. Read More »

The U.S. Food and Drug Administration gave accelerated approval to Praxbind (idarucizumab) on Oct. 16. Praxbind is intended for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects. Praxbind and Pradaxa are marketed by Boehringer Ingelheim of Ridgefield, Connecticut. Read More »

Drug Channels released its review of the Kaiser/HRET 2015 Employer Health Benefits Survey, which examines employer-sponsored health coverage at nearly 2,000 companies, on Oct. 13. “Bottom line: Employers didn’t make major changes this year, but they continue to shift prescription drug costs to beneficiaries and are focusing on specialty drug management,” Drug Channels’ writer Adam Fein said. Read More »